4//SEC Filing
Papiernik Antoine 4
Accession 0001642545-24-000120
CIK 0001642545other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:40 PM ET
Size
8.3 KB
Accession
0001642545-24-000120
Insider Transaction Report
Form 4
Papiernik Antoine
Director10% Owner
Transactions
- Disposition to Issuer
Common Stock
2024-05-31−736→ 0 total - Disposition to Issuer
Common Stock
2024-05-31−34,177→ 0 total(indirect: By Sofinnova Capital VII FCPR)
Footnotes (3)
- [F1]This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"),
- [F2](Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
- [F3]Represents shares directly held by Sofinnova Capital VII FCPR ("Sofinnova VII"). The reporting person is one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of Sofinnova VII. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
Documents
Issuer
Shockwave Medical, Inc.
CIK 0001642545
Entity typeother
Related Parties
1- filerCIK 0001768408
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:40 PM ET
- Size
- 8.3 KB